These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
334 related items for PubMed ID: 18754907
1. Botulinum toxin A injection for children with spastic cerebral palsy. YaJie W, BaoQin G. Dev Med Child Neurol; 2008 Aug; 50(8):640. PubMed ID: 18754907 [No Abstract] [Full Text] [Related]
2. Prospective study examining remote effects of botulinum toxin a in children with cerebral palsy. Crowner BE, Racette BA. Pediatr Neurol; 2008 Oct; 39(4):253-8. PubMed ID: 18805363 [Abstract] [Full Text] [Related]
3. Functional outcome of botulinum toxin injection of gastrocnemius and adductors in spastic hemiplegic cerebral palsied children. Ibrahim AI, Hawamdeh ZM, Al-Qudah AA. Eura Medicophys; 2007 Mar; 43(1):13-20. PubMed ID: 17021584 [Abstract] [Full Text] [Related]
5. Role of exercise testing in the functional assessment of cerebral palsy children after botulinum A toxin injection. Massin M, Allington N. J Pediatr Orthop; 1999 Mar; 19(3):362-5. PubMed ID: 10344321 [Abstract] [Full Text] [Related]
12. Botulinum toxin A in the management of focal muscle overactivity in children with cerebral palsy. Gibson N, Graham HK, Love S. Disabil Rehabil; 2007 Dec 15; 29(23):1813-22. PubMed ID: 18033606 [Abstract] [Full Text] [Related]
13. The expanding role of botulinum toxin type A injections in the management of children with cerebral palsy. Carr LJ. Dev Med Child Neurol; 2009 Sep 15; 51(9):687-8. PubMed ID: 19709139 [No Abstract] [Full Text] [Related]
15. [Upper extremity botulinum toxin treatment in cerebral palsy. Treatment guidelines the first step towards national cooperation]. Arner M, Himmelmann K, Pontén E, Stankovic N, Hansson T, Dahlin LB. Lakartidningen; 2009 Sep 15; 105(43):3009-13. PubMed ID: 19024613 [No Abstract] [Full Text] [Related]
16. Repeat injection of botulinum toxin A is safe and effective for upper limb movement and function in children with cerebral palsy. Lowe K, Novak I, Cusick A. Dev Med Child Neurol; 2007 Nov 15; 49(11):823-9. PubMed ID: 17979860 [Abstract] [Full Text] [Related]
17. Botulinum toxin type A with oral baclofen versus oral tizanidine: a nonrandomized pilot comparison in patients with cerebral palsy and spastic equinus foot deformity. Dai AI, Wasay M, Awan S. J Child Neurol; 2008 Dec 15; 23(12):1464-6. PubMed ID: 19073853 [Abstract] [Full Text] [Related]
18. [Treatment of drooling with botulinum toxin type A in cerebral palsy]. Duarte CS, Alves TR, Azeredo PM, Almeida SI. Rev Neurol; 2008 Dec 15; 49(11):610. PubMed ID: 19921629 [No Abstract] [Full Text] [Related]
19. 'Effectiveness of sedation using nitrous oxide compared with enteral midazolam for botulinum toxin A injections in children'. Gubbay A, Langdon K. Dev Med Child Neurol; 2009 Jun 15; 51(6):491-2; author reply 492. PubMed ID: 19416317 [No Abstract] [Full Text] [Related]
20. [Botulinum toxin A in the treatment of concomitant strabismus in children]. Oleszczyńska-Prost E. Klin Oczna; 2004 Jun 15; 106(1-2):64-7. PubMed ID: 15218768 [Abstract] [Full Text] [Related] Page: [Next] [New Search]